Cipla Quality Chemical Industries Limited, a pharmaceutical manufacturing company, manufactures and delivers anti-retroviral, anti-malarial, and hepatitis B medicines. The company offers Duovir-N; Lamivudine and Zidovudine; Efavir 60; Duomune; Nevirapine; Efavirenz, Lamivudine, and Tenofovir; and Dolutegravir, Lamivudine, and Tenofovir tablets for the treatment of HIV infection. It also offers Lumartem/Lumet tablets for the treatment of malaria; and Texavir and Zentair for the treatment of Hepatitis B. The company was formerly known as Quality Chemicals Industries Limited and changed its name to Cipla Quality Chemical Industries Limited in March 2014. The company was incorporated in 2005 and is based in Kampala, Uganda. Cipla Quality Chemical Industries Limited operates as a subsidiary of Cipla Limited.